ANPCFresh2 Group Ltd


$ 0.59 $ -0.02 (-3.55 %)    

Thursday, 25-Apr-2024 15:46:07 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.5787
$ 0.45
$ 0.00 x 0
$ 0.60 x 100
$ 0.45 - $ 0.59
$ 0.30 - $ 9.17
135,472
na
na
$ 0.68
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 anpac-bio-medical-science-q1-eps-004-up-from-740-yoy-sales-8700k-down-from-33300k-yoy

AnPac Bio-Medical Science (NASDAQ:ANPC) reported quarterly losses of $(0.04) per share. This is a 99.46 percent increase over l...

 why-y-mabs-therapeutics-shares-are-trading-higher-by-50-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quar...

 anpac-bio-medical-science-announces-5-million-private-placement-of-16666665-newly-issued-class-a-ordinary-shares-of-the-company-at-a-price-of-030share-or-us600-per-1-for-20-ads

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) ("AnPac Bio," the "Company" or "we"), a company with ...

 anpac-bio-medical-science-announced-updated-results-from-its-cancer-test-follow-up-study-in-over-18000-individuals-in-china-the-test-subjects-were-tested-using-anpac-bios-cancer-differentiation-analysis-cda-method

Health institutions including hospitals have reported that 2,837 individuals within the study were identified as cancer, pre-...

 anpac-bio-medical-science-enters-into-definitive-agreement-to-acquire-fresh2-ecommerce-inc-a-b2b-asian-food-e-commerce-platform-in-consideration-of-21m-payable-in-the-form-of-5440420-newly-issued-class-a-ordinary-shares-of-the-company

Transaction expected to fuel the Company's growth in the U.S. food market NEW YORK, Feb. 9, 2023 /PRNewswire/ -- AnPac Bio...

 why-transcode-therapeutics-shares-are-trading-higher-by-42-here-are-20-stocks-moving-premarket

Gainers

 electronic-arts-western-digital-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

 anpac-bio-medical-science-announces-signing-of-52m-of-definitive-investment-agreements

AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ:ANPC), a biotechnology company with operations in the Unite...

 anpac-bio-medical-science-in-dec-2022--jan-2023-signed-definitive-investment-agreements-with-several-third-party-investors-investors-agreed-to-purchase-297m-newly-issued-class-a-ordinary-shares-of-co-at-a-price-of-0175share

-Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION